Kimberly-Clark Tops Q3 2026 Estimates as Revenue Rises 0.0% to $4.134B

Kimberly-Clark (KMB) topped estimates for the third quarter of 2026. Revenue was $4.134 billion, up 0.0% from a year earlier, in line with the $4.126 billion estimate, and adjusted EPS was $1.70, down 6.6% from a year earlier, above the $1.65 estimate.

Q3 2026 scorecard

By our calculation, adjusted EPS was $0.05 above it. The QoQ column compares with the previous quarter's revenue of $4.189 billion and adjusted EPS of $1.80. The YoY column compares with $4.133 billion and $1.82 in the same quarter a year earlier.

Track record

• EPS record. Adjusted EPS beat the estimate in 6 of the last 8 reports, including this one.
• Revenue record. Revenue beat the estimate in 3 of the last 8 reports.
• Revenue trend. Revenue over the last 5 reports, oldest first: $4.133 billion, $4.080 billion, $4.163 billion, $4.189 billion and $4.134 billion.

What to watch

• Next-quarter estimates. Consensus calls for EPS of $1.65 and revenue of $4.13 billion next quarter, based on 10 analysts.
• Next report. Kimberly-Clark is next expected to report on Jan. 27, 2027.
• Revenue growth. Whether revenue keeps growing from a year earlier after this quarter's 0.0% increase to $4.134 billion.
• Related coverage. See our reports on Dianthus Therapeutics, Titan America, Personalis and Nutrien.

Sources: Results are from Kimberly-Clark's Nov. 5, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from Kimberly-Clark's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.